隐匿性未控制高血压危险因素及预后的研究进展
Research Progress on Risk Factors and Prognosis of Masked Uncontrolled Hypertension
DOI: 10.12677/acm.2025.1551541, PDF,   
作者: 方君寅：浙江大学医学院附属第四医院，国际医学院，国际健康医学研究院，全科医学科，浙江 义乌；戴红蕾*：浙江大学医学院附属邵逸夫医院全科医学科，浙江 杭州
关键词: 隐匿性未控制高血压；危险因素；预后；研究进展；Masked Uncontrolled Hypertension； Risk Factors； Prognosis； Research Progress
摘要: 隐匿性未控制高血压是指正在接受降压治疗的患者，其诊室血压已达标，但在诊室外测量时仍呈现高血压状态。由于其“隐匿性”的特点，在日常诊疗过程中容易被忽视。近年来，大量研究表明，隐匿性未控制高血压不仅具有较高的患病率，而且其预后情况也不容乐观。持续的诊室外高血压会对患者重要靶器官造成慢性损害，增加心血管疾病等严重并发症的发生风险，这不仅影响了患者的生活质量和生存期限，同时给家庭和社会增加了经济负担。因此，深入分析隐匿性未控制高血压患者的危险因素及预后就显得尤为重要。本文旨在对目前国内外关于隐匿性未控制高血压危险因素及预后的相关研究进行系统总结，为隐匿性未控制高血压的后续综合管理提供理论依据。
Abstract: Masked uncontrolled hypertension refers to patients undergoing antihypertensive treatment who have their office blood pressure within the standard range but continue to exhibit hypertension when measured outside the clinic. Due to its “masked” characteristic, it is easily overlooked during daily diagnosis and treatment. In recent years, a substantial body of research has indicated that MUCH not only exhibits a relatively high prevalence, but also demonstrates an unfavorable prognosis. Persistent out-of-office hypertension can lead to chronic damage to important target organs of patients and elevate the risk of serious complications, such as cardiovascular diseases. This not only compromises the patients’ quality of life and life expectancy but also imposes a significant economic burden on families and society. Therefore, it is particularly important to conduct an in-depth analysis of the risk factors and prognosis of patients with MUCH. This paper aims to systematically summarize the current domestic and international research on the risk factors and prognosis of MUCH, providing a theoretical basis for the subsequent comprehensive management of MUCH.
文章引用：方君寅, 戴红蕾. 隐匿性未控制高血压危险因素及预后的研究进展[J]. 临床医学进展, 2025, 15(5): 1666-1673. https://doi.org/10.12677/acm.2025.1551541

参考文献

[1] Stergiou, G.S., Asayama, K., Thijs, L., Kollias, A., Niiranen, T.J., Hozawa, A., et al. (2014) Prognosis of White-Coat and Masked Hypertension: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome. Hypertension, 63, 675-682. [Google Scholar] [CrossRef] [PubMed]
[2] Rhee, M., Kim, S., Choi, E., Kim, J., Nah, D., Shin, S., et al. (2016) Prevalence of Masked Hypertension: A Population-Based Survey in a Large City by Using 24-Hour Ambulatory Blood Pressure Monitoring. Korean Circulation Journal, 46, 681-687. [Google Scholar] [CrossRef] [PubMed]
[3] Ghazi, L., Cohen, L.P., Muntner, P., Shimbo, D. and Drawz, P.E. (2020) Effects of Intensive versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study. Hypertension, 76, 1090-1096. [Google Scholar] [CrossRef] [PubMed]
[4] Pierdomenico, S.D., Pierdomenico, A.M., Coccina, F., Clement, D.L., De Buyzere, M.L., De Bacquer, D.A., et al. (2018) Prognostic Value of Masked Uncontrolled Hypertension. Hypertension, 72, 862-869. [Google Scholar] [CrossRef] [PubMed]
[5] Andalib, A., Akhtari, S., Rigal, R., Curnew, G., Leclerc, J., Vaillancourt, M., et al. (2012) Determinants of Masked Hypertension in Hypertensive Patients Treated in a Primary Care Setting. Internal Medicine Journal, 42, 260-266. [Google Scholar] [CrossRef] [PubMed]
[6] Diniz, P.G.S., Bezerra, R., Feitosa, C.L.D.M., Gonçalves, T.A.T., Paiva, A.M.G., Mota-Gomes, M.A., et al. (2024) Prevalence of Masked and White-Coat Hypertension among Individuals with Diabetes: Insights from Web-Based Home Blood Pressure Monitoring in the Brazilian Population. Hypertension Research, 47, 3473-3479. [Google Scholar] [CrossRef] [PubMed]
[7] Omboni, S., Aristizabal, D., De la Sierra, A., Dolan, E., Head, G., Kahan, T., et al. (2016) Hypertension Types Defined by Clinic and Ambulatory Blood Pressure in 14143 Patients Referred to Hypertension Clinics Worldwide. Data from the ARTEMIS Study. Journal of Hypertension, 34, 2187-2198. [Google Scholar] [CrossRef] [PubMed]
[8] Diaz, K.M., Veerabhadrappa, P., Brown, M.D., Whited, M.C., Dubbert, P.M. and Hickson, D.A. (2014) Prevalence, Determinants, and Clinical Significance of Masked Hypertension in a Population-Based Sample of African Americans: The Jackson Heart Study. American Journal of Hypertension, 28, 900-908. [Google Scholar] [CrossRef] [PubMed]
[9] Kario, K., Tomitani, N., Buranakitjaroen, P., Chia, Y., Park, S., Chen, C., et al. (2018) Home Blood Pressure Control Status in 2017‐2018 for Hypertension Specialist Centers in Asia: Results of the Asia BP@home Study. The Journal of Clinical Hypertension, 20, 1686-1695. [Google Scholar] [CrossRef] [PubMed]
[10] 李秋云, 张亚静, 李昊轩等. 隐蔽性未控制高血压的影响因素[J]. 中华高血压杂志, 2018, 26(11): 1041-1047.
[11] Banegas, J.R., Ruilope, L.M., de la Sierra, A., de la Cruz, J.J., Gorostidi, M., Segura, J., et al. (2014) High Prevalence of Masked Uncontrolled Hypertension in People with Treated Hypertension. European Heart Journal, 35, 3304-3312. [Google Scholar] [CrossRef] [PubMed]
[12] Holanger, M., Kjeldsen, S.E., Jamerson, K. and Julius, S. (2020) Smoking and Overweight Associated with Masked Uncontrolled Hypertension: A Hypertension Optimal Treatment (HOT) Sub-Study. Blood Pressure, 30, 51-59. [Google Scholar] [CrossRef] [PubMed]
[13] Benowitz, N.L. and Burbank, A.D. (2016) Cardiovascular Toxicity of Nicotine: Implications for Electronic Cigarette Use. Trends in Cardiovascular Medicine, 26, 515-523. [Google Scholar] [CrossRef] [PubMed]
[14] Haass, M. and Kübler, W. (1997) Nicotine and Sympathetic Neurotransmission. Cardiovascular Drugs and Therapy, 10, 657-665. [Google Scholar] [CrossRef] [PubMed]
[15] BOLINDER, G. and DEFAIRE, U. (1998) Ambulatory 24-H Blood Pressure Monitoring in Healthy, Middle-Aged Smokeless Tobacco Users, Smokers, and Nontobacco Users. American Journal of Hypertension, 11, 1153-1163. [Google Scholar] [CrossRef] [PubMed]
[16] Oakes, J.M., Fuchs, R.M., Gardner, J.D., Lazartigues, E. and Yue, X. (2018) Nicotine and the Renin-Angiotensin System. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 315, R895-R906. [Google Scholar] [CrossRef] [PubMed]
[17] 李青, 刘自州, 孙晓楠, 等. 肥胖的病因、流行病学与心血管风险因素[J]. 临床内科杂志, 2025, 42(1): 1-4.
[18] Xia, J., Zhang, D., Kang, Y., Guo, Q., Cheng, Y., Huang, J., et al. (2022) The Prevalence of Masked Hypertension and Masked Uncontrolled Hypertension in Relation to Overweight and Obesity in a Nationwide Registry in China. Hypertension Research, 45, 1690-1700. [Google Scholar] [CrossRef] [PubMed]
[19] Figliuzzi, I., Presta, V., Miceli, F., Citoni, B., Coluccia, R., Ceccarini, G., et al. (2018) 24-Hour Ambulatory Blood Pressure Levels and Control in a Large Cohort of Adult Outpatients with Different Classes of Obesity. Journal of Human Hypertension, 33, 298-307. [Google Scholar] [CrossRef] [PubMed]
[20] de Heredia, F.P., Gómez-Martínez, S. and Marcos, A. (2012) Obesity, Inflammation and the Immune System. Proceedings of the Nutrition Society, 71, 332-338. [Google Scholar] [CrossRef] [PubMed]
[21] 穆文娟, 杨丽洁, 宋赛赛, 等. 不同脂肪组织与动脉粥样硬化关系的研究进展[J]. 生命科学, 2021, 33(2): 166-175.
[22] Özkan, S., Ata, N. and Yavuz, B. (2018) Increased Masked Hypertension Prevalence in Patients with Obesity. Clinical and Experimental Hypertension, 40, 780-783. [Google Scholar] [CrossRef] [PubMed]
[23] Hall, J.E., Mouton, A.J., da Silva, A.A., Omoto, A.C.M., Wang, Z., Li, X., et al. (2020) Obesity, Kidney Dysfunction, and Inflammation: Interactions in Hypertension. Cardiovascular Research, 117, 1859-1876. [Google Scholar] [CrossRef] [PubMed]
[24] Landsberg, L., Aronne, L.J., Beilin, L.J., Burke, V., Igel, L.I., Lloyd‐Jones, D., et al. (2012) Obesity‐Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment—A Position Paper of the The Obesity Society and the American Society of Hypertension. Obesity, 21, 8-24. [Google Scholar] [CrossRef] [PubMed]
[25] Lithovius, R., Gordin, D., Forsblom, C., Saraheimo, M., Harjutsalo, V. and Groop, P. (2018) Ambulatory Blood Pressure and Arterial Stiffness in Individuals with Type 1 Diabetes. Diabetologia, 61, 1935-1945. [Google Scholar] [CrossRef] [PubMed]
[26] Khan, A.W. and Jandeleit-Dahm, K.A.M. (2025) Atherosclerosis in Diabetes Mellitus: Novel Mechanisms and Mechanism-Based Therapeutic Approaches. Nature Reviews Cardiology. [Google Scholar] [CrossRef] [PubMed]
[27] Franklin, S.S., Thijs, L., Li, Y., Hansen, T.W., Boggia, J., Liu, Y., et al. (2013) Masked Hypertension in Diabetes Mellitus: Treatment Implications for Clinical Practice. Hypertension, 61, 964-971. [Google Scholar] [CrossRef] [PubMed]
[28] Chia, Y., Kario, K., Tomitani, N., Park, S., Shin, J., Turana, Y., et al. (2019) Comparison of Day‐to‐Day Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes Mellitus to Those without Diabetes: Asia BP@home Study. The Journal of Clinical Hypertension, 22, 407-414. [Google Scholar] [CrossRef] [PubMed]
[29] Kim, H., Shin, J., Lee, Y., Kim, J.H., Hwang, S.H., Kim, W.S., et al. (2021) Clinical Features and Predictors of Masked Uncontrolled Hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry. The Korean Journal of Internal Medicine, 36, 1102-1114. [Google Scholar] [CrossRef] [PubMed]
[30] 李雪, 龚开凤, 丁森华, 等. 心血管病高危人群的隐匿性高血压检出率及相关筛查指标研究[J]. 心脑血管病防治, 2020, 20(6): 561-565.
[31] Leslie, K.H., McCowan, C. and Pell, J.P. (2018) Adherence to Cardiovascular Medication: A Review of Systematic Reviews. Journal of Public Health, 41, e84-e94. [Google Scholar] [CrossRef] [PubMed]
[32] Franklin, S.S., O’Brien, E. and Staessen, J.A. (2016) Masked Hypertension: Understanding Its Complexity. European Heart Journal, 38, 1112-1118. [Google Scholar] [CrossRef] [PubMed]
[33] Cacciolati, C., Tzourio, C. and Hanon, O. (2012) Blood Pressure Variability in Elderly Persons with White-Coat and Masked Hypertension Compared to Those with Normotension and Sustained Hypertension. American Journal of Hypertension, 26, 367-372. [Google Scholar] [CrossRef] [PubMed]
[34] Sova, M., Genzor, S., Sovova, M., Sovova, E., Moravcova, K., Nadjarpour, S., et al. (2020) High Incidence of Masked Hypertension in Patients with Obstructive Sleep Apnoea Despite Normal Automated Office Blood Pressure Measurement Results. Advances in Respiratory Medicine, 88, 567-573. [Google Scholar] [CrossRef] [PubMed]
[35] Pierdomenico, S.D., Pierdomenico, A.M., Coccina, F. and Porreca, E. (2017) Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients. American Journal of Hypertension, 30, 1106-1111. [Google Scholar] [CrossRef] [PubMed]
[36] Ruilope, L.M., Ruiz-Hurtado, G., Barderas, M.G., de la Cruz, J.J., Lucia, A., de la Sierra, A., et al. (2019) Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals. Hypertension, 74, 130-136. [Google Scholar] [CrossRef] [PubMed]
[37] Li, Y., Staessen, J.A., Lu, L., Li, L., Wang, G. and Wang, J. (2007) Is Isolated Nocturnal Hypertension a Novel Clinical Entity? Findings from a Chinese Population Study. Hypertension, 50, 333-339. [Google Scholar] [CrossRef] [PubMed]
[38] Fujiwara, T., Hoshide, S., Kanegae, H. and Kario, K. (2020) Cardiovascular Event Risks Associated with Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study. Hypertension, 76, 259-266. [Google Scholar] [CrossRef] [PubMed]
[39] Cuspidi, C., Facchetti, R., Bombelli, M., Sala, C., Tadic, M., Grassi, G., et al. (2017) Is Night-Time Hypertension Worse than Daytime Hypertension? A Study on Cardiac Damage in a General Population: The PAMELA Study. Journal of Hypertension, 35, 506-512. [Google Scholar] [CrossRef] [PubMed]
[40] Cho, M. (2019) Clinical Significance and Therapeutic Implication of Nocturnal Hypertension: Relationship between Nighttime Blood Pressure and Quality of Sleep. Korean Circulation Journal, 49, 818-828. [Google Scholar] [CrossRef] [PubMed]
[41] Rahman, M., Wang, X., Bundy, J.D., Charleston, J., Cohen, D., Cohen, J., et al. (2020) Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology, 31, 2609-2621. [Google Scholar] [CrossRef] [PubMed]
[42] Agarwal, R. (2016) Albuminuria and Masked Uncontrolled Hypertension in Chronic Kidney Disease. Nephrology Dialysis Transplantation, 32, 2058-2065. [Google Scholar] [CrossRef] [PubMed]
[43] Mancia, G., Facchetti, R., Cuspidi, C., Bombelli, M., Corrao, G. and Grassi, G. (2019) Limited Reproducibility of MUCH and WUCH: Evidence from the ELSA Study. European Heart Journal, 41, 1565-1571. [Google Scholar] [CrossRef] [PubMed]
[44] Mancia, G., Facchetti, R., Vanoli, J., Dolfini, V. and Grassi, G. (2022) Reproducibility of Blood Pressure Phenotypes Identified by Office and Ambulatory Blood Pressure in Treated Hypertensive Patients. Data from the PHYLLIS Study. Hypertension Research, 45, 1599-1608. [Google Scholar] [CrossRef] [PubMed]

为你推荐